background
toxoplasmosi
caus
loss
life
cognit
motor
function
sight
vaccin
greatli
need
prevent
diseas
purpos
studi
use
immmunosens
approach
develop
foundat
develop
vaccin
protect
human
supertyp
three
peptid
identifi
high
bind
score
supertyp
use
bioinformat
algorhythm
high
measur
bind
affin
supertyp
molecul
abil
elicit
product
human
supertyp
peripher
blood
cell
seroposit
seroneg
person
result
herein
peptid
administ
univers
cell
epitop
padr
akfvaawtlkaaa
formul
lipopeptid
administ
glase
either
alon
pam
cy
ad
found
success
creat
prepar
induc
reduc
parasit
burden
hlaa
supertyp
allel
transgen
mice
glase
novel
emulsifi
synthet
ligand
known
facilit
develop
helper
cell
respons
peptid
would
includ
express
tachyzoit
bradyzoit
sporozoit
type
ii
parasit
use
approach
identifi
initi
peptid
identifi
addit
peptid
use
bioinformat
bind
affin
assay
studi
respons
human
cell
lastli
found
immun
hlaa
transgen
mice
pool
peptid
administ
padr
glase
pam
cy
effect
way
elicit
produc
splenic
cell
protect
immun
includ
follow
peptid
togeth
ksfkdilpk
amltafflr
rsfkdllkk
stfwpcllr
ssayvfsvk
avvsllrllk
spa
immun
elicit
robust
protect
measur
reduc
parasit
burden
use
luciferas
transfect
parasit
luciferin
novel
hla
transgen
mous
model
imag
xenogen
camera
conclus
toxoplasma
gondii
peptid
elicit
restrict
produc
cell
human
mice
peptid
administ
adjuv
reduc
parasit
burden
hlaa
transgen
mice
work
provid
foundat
immunosens
base
vaccin
also
defin
novel
adjuv
newli
identifi
peptid
vaccin
prevent
toxoplasmosi
supertyp
allel
toxoplasmosi
diseas
major
medic
import
toxoplasma
gondii
caus
congenit
infect
respons
stillbirth
spontan
abort
addit
caus
neurolog
disord
uveiti
system
infect
immunecompromis
patient
toxoplasm
enceph
caus
morbid
mortal
congenit
diseas
person
aid
gondii
acquir
consumpt
lightli
cook
meat
especi
lamb
pork
contamin
bradyzoit
ingest
food
water
contamin
oocyst
contain
sporozoit
product
sexual
cycl
intestin
cat
develop
effect
vaccin
would
prevent
diseas
attenu
gondii
tachyzoit
eg
employ
live
vaccin
nonhuman
anim
parasit
attenu
knockout
gene
transcript
recent
propos
new
type
attenu
vaccin
candid
howev
safeti
consider
may
limit
vaccin
human
live
organ
develop
peptidebas
vaccin
creat
epitop
elicit
product
cell
promis
strategi
mobil
immun
system
gondii
human
thu
effort
creat
immunosens
epitopebas
vaccin
initi
recent
three
peptid
epitop
ksfkdilpk
amltafflr
rsfkd
llkk
found
group
elicit
peripher
blood
mononuclear
leukocyt
pbmc
gondii
seroposit
supertyp
human
pbmc
gondii
seroneg
supertyp
human
herein
initi
design
cell
epitop
contain
vaccin
formul
compris
lipopeptid
incorpor
padr
well
novel
oilinwat
emuls
includ
special
formul
synthet
mla
deriv
call
glase
first
efficaci
variou
vaccin
formul
consist
three
previous
identifi
cell
peptid
elicit
hlaa
cellmedi
product
vitro
hlaa
mice
examin
order
identifi
addit
peptid
gondii
tachyzoit
bradyzoit
sporozoit
type
type
ii
strain
effect
elicit
supertyp
restrict
cell
first
step
select
protein
biolog
properti
secret
compat
mhc
class
process
bioinformat
algorithm
identifi
supertyp
bound
peptid
util
find
addit
novel
gondiideriv
potenti
cell
elicit
epitop
restrict
supertyp
screen
peptid
tachyzoit
bradyzoit
sporozoit
protein
spa
mic
type
ii
gondii
strain
search
high
bind
score
bioinformat
analysi
ic
nm
bind
assay
addit
peripher
blood
mononuclear
cell
seroposit
seroneg
person
test
respons
peptid
use
elispot
assay
latter
studi
perform
attempt
identifi
peptid
would
promis
candid
inclus
multiepitop
next
gener
immunosens
vaccin
inform
obtain
test
first
three
peptid
studi
use
guid
formul
administr
peptid
pool
pool
includ
first
three
peptid
identifi
earlier
test
initi
experi
combin
newli
identifi
peptid
elicit
human
supertyp
restrict
cell
peptid
pool
test
univers
helper
epitop
call
padr
new
promis
adjuv
call
glase
pam
cy
hlaa
transgen
mice
capac
induc
product
spleen
cell
protect
parasit
burden
follow
subsequ
challeng
determin
parasit
challeng
luciferas
transfect
type
ii
prugneaud
parasit
administ
follow
luciferin
administr
imag
xenogen
camera
system
week
later
allow
detect
quantiz
bioluminesc
parasit
biomark
assess
efficaci
immun
protect
three
cell
epitop
identifi
gondii
protein
base
signific
recognit
cell
gondii
seroposit
individu
univers
cell
epitop
padr
akfvaawtlkaaa
link
sequenc
ntermin
end
three
differ
gondii
cell
epitop
ksfkdilpk
amltafflr
rsfkdllkk
also
three
epitop
link
togeth
three
alanin
linker
ntermin
end
result
peptid
polypeptid
extend
lysin
coval
link
two
molecul
palmit
acid
moieti
lipopeptid
lp
name
shown
figur
immunogen
lipopeptid
hlaa
transgen
mice
hlaa
transgen
mice
immun
twice
interv
three
week
lipopeptid
administ
pb
two
week
last
immun
spleen
remov
immun
mice
abil
splenocyt
produc
upon
stimul
peptid
analyz
transgen
mice
immun
three
singl
peptid
lipopeptid
vaccin
cell
produc
figur
lipopeptid
vaccin
stimul
higher
product
figur
howev
three
peptid
epitop
link
togeth
stimul
strong
respons
splenocyt
mice
expos
individu
peptid
vitro
result
achiev
statist
signific
figur
order
determin
formul
immunogen
vaccin
singl
peptid
mixtur
peptid
compar
link
lipopeptid
vaccin
result
repres
experi
present
figur
mice
immun
vaccin
formul
singl
peptid
adjuv
glase
pam
cy
elicit
product
mean
sem
fourfold
higher
p
mice
receiv
glase
vaccin
figur
similar
result
substanti
product
found
splenocyt
mice
immun
mixtur
peptid
adjuv
result
compar
product
splenocyt
mice
immun
lipopeptid
vaccin
construct
three
peptid
link
togeth
alanin
spacer
signific
product
present
stimul
spleen
cell
much
less
robust
signific
spleen
cell
stimul
peptid
determin
whether
adjuv
effect
immunogen
peptid
hlaa
transgen
mice
immun
pool
peptid
includ
three
peptid
alon
vari
adjuv
hlaa
transgen
mice
immun
epitop
peptid
pool
peptid
pool
plu
padr
peptid
pool
figur
schemat
represent
synthet
lipopeptid
immunogen
use
studi
ctermin
end
promiscu
cell
peptid
epitop
padr
join
sequenc
ntermin
end
one
three
differ
gondii
cell
epitop
b
c
three
epitop
link
togeth
three
alanin
linker
ntermin
end
result
peptid
extend
lysin
coval
link
one
molecul
palmit
acid
result
four
lipopeptid
construct
abbrevi
lp
use
throughout
manuscript
whenev
lipopeptid
lp
studi
mixtur
compon
undivid
compon
name
individu
sequenc
padr
akfvaawtlkaaa
structur
pam
cy
pam
kss
abbrevi
name
protein
peptid
deriv
figur
mice
immun
twice
interv
three
week
ten
fourteen
day
last
immun
spleen
cell
separ
immun
mice
stimul
appropri
peptid
ex
vivo
elispot
assay
data
present
averag
three
independ
replic
experi
p
p
figur
use
immunogen
lipopeptid
immun
mice
vaccin
twice
interv
three
week
immun
contain
individu
compon
includ
peptid
mice
vaccin
three
time
interv
two
week
ten
fourteen
day
last
immun
spleen
cell
separ
immun
mice
stimul
appropri
peptid
ex
vivo
elispot
assay
data
present
repres
exampl
three
independ
experi
p
p
plu
padr
emulsifi
glase
peptid
pool
plu
padr
pam
cy
emulsifi
glase
mice
inocul
three
time
interv
two
week
eleven
fourteen
day
post
immun
spleen
cell
isol
expos
individu
peptid
peptid
consid
immunogen
induc
spot
format
significantli
higher
immun
group
compar
group
inocul
pb
immun
found
immunogen
hlaa
transgen
mice
inivers
helper
cell
peptid
epitop
padr
includ
robust
respons
observ
glase
ad
vaccin
greater
respons
elicit
pam
cy
use
adjuv
peptid
enhanc
respons
fact
reduc
effect
peptid
figur
show
repres
data
spot
format
four
immun
group
stimul
individu
peptid
vaccin
peptid
pool
adjuv
protect
mice
type
ii
parasit
challeng
hlaa
transgen
mice
immun
peptid
pool
plu
padr
pam
cy
glase
three
time
interv
two
week
mice
challeng
week
last
immun
imag
day
challeng
pru
fluc
use
xenogen
vivo
imag
system
shown
figur
number
luciferas
express
parasit
immun
hlaa
transgen
mice
significantli
less
compar
number
parasit
unimmun
mice
mean
immun
mice
differ
signific
eg
p
pool
experi
use
natur
log
transform
data
twosampl
test
initi
identifi
epitop
provid
protect
parasit
challeng
next
gener
vaccin
might
even
robust
elicit
cell
would
effect
three
life
cycl
stage
type
ii
genet
type
parasit
sought
identifi
addit
epitop
use
vaccin
develop
order
identifi
addit
peptid
gondii
present
tachyzoit
bradyzoit
sporozoit
type
ii
strain
supertyp
restrict
cell
screen
candid
peptid
tachyzoit
bradyzoit
sporozoit
protein
spa
mic
type
ii
gondii
strain
tabl
parsimoni
number
peptid
util
attempt
includ
peptid
present
type
well
type
ii
parasit
genet
type
peripher
blood
mononuclear
cell
seroposit
gondii
donor
test
respons
peptid
use
elispot
assay
pool
peptid
test
initi
pool
significantli
differ
p
control
data
shown
individu
peptid
test
figur
three
epitop
elicit
respons
greater
sfc
seroposit
donor
pbmc
seroneg
donor
pbmc
figur
peptid
protein
deriv
stfwpcllr
ssayvfsvk
spa
avvsllrllk
spa
ad
protein
express
sporozoit
bradyzoit
peptid
select
peptid
identifi
herein
found
show
high
bind
affin
three
five
supertyp
allel
mhcpeptid
bind
assay
tabl
number
tabl
indic
high
bind
affin
less
ic
nm
indic
bold
font
number
tabl
vaccin
peptid
pool
includ
newli
identifi
peptid
adjuv
elicit
ifng
provid
protect
mice
type
ii
parasit
challeng
hlaa
transgen
mice
immun
peptid
pool
includ
newli
identifi
peptid
ksfkdilpk
amltafflr
rsfkdllkk
stfwpcllr
ssayvfsvk
spa
avvsllrllk
spa
plu
padr
pam
cy
glase
immun
three
time
interv
two
week
signific
spot
format
respons
observ
vitro
cell
immun
mice
expos
peptid
except
figur
show
repres
data
spot
format
four
immun
group
stimul
individu
peptid
inclus
newli
identifi
peptid
thu
potenti
enhanc
immunogen
transgen
hlaa
mice
mice
challeng
week
last
immun
imag
five
day
challeng
pru
fluc
use
xenogen
vivo
imag
system
shown
initi
experi
figur
number
luciferas
express
parasit
immun
hlaa
mice
significantli
reduc
compar
number
parasit
unimmun
mice
result
algorithm
develop
calcul
project
popul
coverag
cell
epitopebas
vaccin
use
mhc
bind
cell
restrict
data
hla
gene
frequenc
use
webbas
tool
http
wwwiedborg
predict
popul
coverag
supertyp
peptid
epitopesbas
vaccin
popul
coverag
calcul
result
tabl
indic
coverag
vari
differ
geograph
region
supertyp
molecul
present
peptid
would
expect
present
studi
first
evalu
immun
hlaa
transgen
mice
either
mixtur
peptid
lipopeptid
deriv
three
identifi
gondii
specif
hlaa
restrict
cell
epitop
emulsifi
monophosphoryl
lipid
glase
adjuv
immun
transgen
mice
mixtur
epitop
peptid
pool
plu
padr
adjuv
abl
induc
splenocyt
produc
protect
challeng
high
number
type
ii
parasit
conjug
cell
determin
lipid
group
known
enhanc
specif
cellmedi
respons
target
antigen
experiment
anim
human
although
mechan
wherebi
immun
achiev
remain
poorli
understood
lipopeptid
hold
sever
advantag
convent
vaccin
formul
instanc
selfadjuv
display
none
toxicityassoci
side
effect
adjuv
system
work
transgen
mice
immun
three
short
lipopeptid
vaccin
cell
produc
among
lipopeptid
vaccin
formul
vivo
protect
demonstr
imag
use
xenogen
camera
hlaa
transgen
mice
immun
peptid
pool
adjuv
protect
compar
control
mice
inocul
pb
challeng
prugneaud
strain
fluc
gondii
luciferas
express
parasit
total
usual
per
group
mice
test
control
immun
group
differ
control
immun
group
signific
p
use
natur
log
transform
data
twosampl
test
peptid
deriv
protein
posit
within
protein
bind
affin
perform
mhc
bind
assay
pbmc
four
gondiiseroposit
supertyp
person
four
seroneg
person
stimul
peptid
cell
produc
test
elispot
assay
splenic
cell
isol
hlaa
supertyp
includ
hlaa
haplotyp
mice
day
peptid
immun
test
abil
gener
respons
peptid
stimul
higher
product
lipopeptid
vaccin
formul
unexplain
variabl
respons
observ
high
affin
bind
peptid
model
eg
studi
livingston
alexand
sett
et
al
lassa
fever
viru
interest
better
understand
possibl
mechan
lack
respons
futur
studi
howev
lipopeptid
three
epitop
peptid
link
togeth
alanin
spacer
stimul
respons
splenocyt
immun
mice
splenocyt
subsequ
expos
peptid
vitro
reason
lipopeptid
three
link
peptid
work
well
transgen
mice
might
relat
frame
shift
caus
linker
alter
respons
origin
peptid
rather
alanin
function
intend
purpos
introduc
cleavag
motif
three
linker
aaa
peptid
previous
demonstr
system
result
sensit
link
peptid
howev
surprisingli
appear
work
well
herein
three
link
peptid
lipopeptid
formul
effect
found
mixtur
compon
singl
peptid
robust
lipopeptid
tri
approach
three
peptid
includ
link
lipopeptid
univers
helper
cell
peptid
padr
adjuv
describ
respons
robust
vitro
vivo
figur
studi
shown
palmitoyl
lipopeptid
construct
elicit
longliv
protect
cellular
respons
varieti
pathogen
includ
hepat
b
viru
hbv
influenza
viru
plasmodium
falciparum
work
herein
show
mice
immun
mixtur
elicit
peptid
lipid
pam
cy
emulsifi
glase
elicit
higher
product
mice
immun
lipopeptid
construct
compon
elicit
peptid
pam
cy
approach
use
cocktail
noncoval
link
lipid
mix
helper
lymphocyt
htl
cell
cytolyt
lymphcyt
ctl
elicit
epitop
simultan
induct
multipl
specif
would
signific
advantag
term
eas
vaccin
develop
htl
respons
crucial
develop
respons
least
case
lipid
coval
noncoval
link
htlctl
epitop
construct
formul
pb
sever
previou
studi
illustr
role
respons
develop
ctl
respons
human
experiment
anim
inclus
padr
synthet
peptid
bind
promiscu
variant
figur
new
peptid
test
pbmc
seroposit
seroneg
donor
peripher
blood
mononuclear
cell
seroposit
gondii
donor
test
respons
predict
supertyp
restrict
cell
epitop
individu
peptid
use
elispot
assay
peptid
induc
signific
spot
format
compar
dmso
denot
asterisk
p
figur
addit
peptid
pool
robustli
protect
hlaa
mice
type
ii
parasit
challeng
hlaa
transgen
mice
immun
pb
control
peptid
pool
padr
pam
cy
glase
splenic
cell
isol
day
post
immun
expos
peptid
ex
vivo
elispot
assay
figur
hlaa
transgen
mice
immun
peptid
pool
adjuv
protect
compar
control
mice
inocul
pb
challeng
pru
fluc
gondii
luciferas
express
parasit
figur
mice
immun
subgroup
immun
function
studi
time
challeng
shown
perform
differ
control
immun
mice
signific
p
use
natur
log
transform
data
twosampl
test
human
mhc
class
ii
molecul
dr
effect
mice
also
augment
cell
effector
function
induc
helper
cell
epitop
target
order
drive
protect
immun
respons
adjuv
antigen
contribut
success
vaccin
exampl
herein
monophosphoryl
lipid
glase
detoxifi
deriv
lipopolysaccharid
lp
salmonella
minnesota
potent
adjuv
glase
novel
adjuv
formul
emuls
tolllik
receptor
agonist
potent
activ
respons
use
adjuv
human
vaccin
trial
sever
infecti
diseas
malign
indic
effect
adjuv
provid
cell
help
immun
protozoan
infect
leishmaniasi
studi
robust
respons
observ
glase
includ
prepar
immun
mice
pam
cy
palmitoyloxi
propyl
cystein
lipid
compon
macrophageactiv
lipopeptid
pam
cy
bind
activ
dendrit
cell
engag
tolllik
receptor
tolllik
receptor
tlr
function
patternrecognit
receptor
mammal
found
receptor
particip
human
host
defens
gondii
infect
activ
gpi
gipl
melo
hargrav
miller
blackwel
gazinelli
mcleod
et
al
prepar
like
work
togeth
receptor
includ
tlr
elicit
effect
host
respons
gondii
infect
studi
slightli
robust
respons
observ
pam
cy
coadminist
peptid
goal
present
studi
identifi
hlarestrict
epitop
gondii
evalu
whether
could
provid
protect
parasit
challeng
measur
protect
luciferas
produc
type
parasit
use
xenogen
camera
system
futur
addit
detail
studi
involv
analys
longer
time
strain
parasit
challeng
life
cycl
stage
evalu
multipl
organ
includ
eye
brain
studi
protect
congenit
infect
comparison
deliveri
peptid
dna
encod
versu
formul
futur
work
follow
extend
intiti
studi
reduct
parasit
burden
seen
figur
variou
peptidebas
approach
induct
respons
evalu
part
ongo
effort
develop
immunosens
vaccin
use
human
supermotif
would
total
includ
human
popul
worldwid
robust
protect
achiev
hlaa
transgen
mice
challeng
type
ii
parasit
follow
immun
order
identifi
addit
peptid
gondii
present
tachyzoit
bradyzoit
sporozoit
type
ii
strain
elicit
supertyp
includ
hla
allel
restrict
cell
bioinformat
algorithm
util
identifi
novel
gondiideriv
epitop
restrict
supertyp
pbmc
cell
test
determin
whether
peptid
elicit
human
cell
seroposit
person
intend
collect
provid
broad
coverag
human
popul
supertyp
worldwid
addit
peptid
identifi
immunogen
human
peripher
blood
cell
also
robust
elicit
splenocyt
hlaa
mice
protect
use
immun
mice
find
facilit
develop
immunosens
epitopebas
vaccin
human
use
human
immunomebas
parasit
genom
base
bioinformatic
approach
use
defin
candid
supertyp
restrict
peptid
immunogen
group
gondii
supertyp
restrict
peptid
therefor
protein
deriv
immun
human
hlaa
transgen
mice
demonstr
peptid
elicit
product
human
cell
also
elicit
interferon
product
mous
splenocyt
util
immun
hlaa
transgen
mice
lipopeptid
univers
cell
elicit
epitop
padr
peptid
pool
padr
pam
cy
glase
novel
adjuv
immun
studi
demonstr
need
efficaci
adjuv
immun
hla
transgen
mice
immunogen
peptid
includ
ksfkdilpk
amltafflr
rsfkdllkk
stfwbcllr
ssayvfsvk
spa
avvsllrllk
spa
studi
herein
provid
foundat
immunosens
base
vaccin
prevent
toxoplasmosi
supertyp
inform
adjuv
supertyp
cell
epitop
includ
ksfkdilpk
amltafflr
rsfkdllkk
padr
akfvaawtlkaaa
univers
helper
peptid
use
vaccin
construct
pam
cy
pam
kss
also
includ
lipopeptid
construct
use
studi
shown
figur
peptid
lipopeptid
synthes
synthet
biomolecul
san
diego
puriti
addit
supertyp
bound
peptid
initi
group
pool
vitro
studi
shown
tabl
agonist
glase
adjuv
synthes
infecti
diseas
research
institut
seattl
washington
stabl
oilinwat
emuls
amltafflr
addit
new
peptid
first
dissolv
dmso
dilut
pb
hlaa
b
transgen
mice
produc
pharmexaepimmun
san
diego
ca
bred
univers
chicago
hlaa
b
transgen
mice
express
chimer
gene
consist
domain
hlaa
domain
b
creat
background
test
use
mice
group
experi
repeat
time
experi
figur
perform
includ
subgroup
analyz
immun
respons
parallel
subgroup
challeng
shown
studi
conduct
approv
institut
anim
care
use
committe
univers
chicago
transgen
gondii
use
vivo
challeng
deriv
type
ii
prugniaud
pru
strain
express
firefli
luciferas
fluc
gene
constitut
tachyzoit
bradyzoit
creat
kindli
provid
kim
j
boothroyd
j
saeij
stanford
univers
maintain
util
previous
describ
evalu
peptid
immunogen
hlaa
transgen
mice
inocul
subcutan
sc
base
tail
use
needl
singl
peptid
mixtur
cell
peptid
peptid
per
mous
padr
akfvaawtlkaaa
emulsifi
glase
agonist
without
pam
cy
pam
cy
concentr
mgml
immun
lipopeptid
hlaa
mice
receiv
nmol
lipopeptid
dissolv
pb
emulsifi
glase
control
mice
inject
pb
pbsglase
lipopeptid
immun
mice
vaccin
twice
interv
three
week
peptid
immun
mice
immun
three
time
interv
two
week
challeng
studi
mice
immun
peptid
emuls
challeng
intraperiton
ip
day
postimmun
use
type
ii
parasit
mice
infect
prufluc
tachyzoit
imag
day
postchalleng
use
vivo
imag
system
ivi
xenogen
alameda
ca
mice
inject
ip
dluciferin
anesthet
rich
induct
chamber
isofluran
imag
minut
photon
emiss
assess
use
live
softwar
xenogen
data
present
pseudocolor
represent
light
intens
mean
photonsregion
interest
roi
mous
experi
repeat
least
twice
mice
group
experi
figur
subgroup
mice
use
studi
immun
respons
parallel
subgroup
challeng
shown
mice
euthan
day
immun
spleen
harvest
press
screen
form
singlecel
suspens
deplet
erythrocyt
akc
lysi
buffer
mm
nh
cl
mm
khco
edta
splenocyt
wash
twice
hank
balanc
salt
solut
hbss
resuspend
complet
rpmi
medium
supplement
mm
lglutamax
invitrogen
uml
penicillin
streptomycin
mm
sodium
pyruv
mercaptoethanol
fc
use
subsequ
vitro
assay
peptid
concentr
mgml
use
per
well
elispot
assay
murin
splenocyt
perform
use
mab
biotinyl
mab
cytokinespecif
captur
antibodi
antibodi
monoclon
antibodi
splenocyt
plate
per
well
pbmc
obtain
hla
haplotyp
determin
process
cryopreserv
describ
elispot
assay
human
pbmc
similar
murin
splenocyt
use
mab
biotinyl
mab
pbmc
per
well
antibodi
reagent
use
elispot
assay
mabtech
cincinnati
oh
antibodi
monoclon
antibodi
murin
human
cell
plate
least
replic
well
condit
result
express
number
spot
form
cell
sfc
per
pbmc
per
murin
splenocyt
protein
sequenc
deriv
spa
mic
analyz
cell
epitop
base
predict
bind
affin
supertyp
molecul
use
arb
algorithm
immunoepitop
databas
iedb
http
wwwimmuneepitopeorg
total
uniqu
peptid
ic
nm
rank
nonamer
peptid
select
protein
sequenc
toxodb
quantit
assay
measur
bind
peptid
hla
class
molecul
base
inhibit
bind
radiolabel
standard
peptid
assay
describ
concentr
peptid
yield
inhibit
bind
radiolabel
probe
peptid
ic
statist
analys
vitro
assay
perform
use
student
test
natur
log
transform
data
twosampl
test
use
analyz
data
shown
figur
twotail
p
valu
consid
statist
signific
peptid
consid
immunogen
mice
induc
spot
format
immun
mice
signific
p
compar
spot
format
control
mice
mous
experi
repeat
least
twice
mice
group
experi
figur
determin
immun
respons
imag
mice
parallel
